Live Breaking News & Updates on Her2 Positive Or Low Metastatic Breast Cancer

Stay updated with breaking news from Her2 positive or low metastatic breast cancer. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

T-DXd Demonstrates Real-World Efficacy in Advanced Breast Cancer With Dynamic HER2 Expression

Administration of fam-trastuzumab deruxtecan significantly prolonged time-to-next treatment in patients with HER2-positive or HER2-low metastatic breast cancer, including patients who experienced changes in HER2 status during the treatment course. ....

San Antonio , United States , Paolo Tarantino , Dana Farber Cancer Institute , Duke Cancer Center , Antonio Breast Cancer , Duke Cancer , Breast Cancer , Fam Trastuzumab Deruxtecan , 2023 San Antonio Breast Cancer Symposium , Her2 Positive Or Low Metastatic Breast Cancer ,